ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
전문 제네릭 의약품 시장 규모는 최근 급성장하고 있습니다. 2025년 1,071억 4,000만 달러에서 2026년에는 1,227억 달러에 이르고, CAGR 14.5%의 성장이 전망되고 있습니다. 지금까지의 성장은 자가면역질환 유병률 증가, 브랜드 전문의약품의 특허 만료, 헬스케어 인프라에 대한 투자 증가, 병원 및 소매 약국 네트워크 확대, 주요 시장에서의 바이오시밀러의 조기 도입 등이 주요 요인으로 꼽힙니다.
특수 제네릭 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 2,142억 2,000만 달러에 이르고, CAGR은 14.9%를 나타낼 전망입니다. 예측 기간 동안의 성장 요인으로는 특수 제네릭 제품 포트폴리오의 확대, 생물학적 제제 제조 기술의 발전, 헬스케어 지출 증가, 개인 맞춤형 치료에 대한 수요 증가, 제약사와 CDMO(위탁개발생산기관)간의 제휴 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 바이오의약품 및 바이오시밀러 도입 확대, 전문 약국 서비스 확대, 개인 맞춤형 의료의 통합, 규제 준수 복잡성 증가, 만성질환 치료 수요 증가 등을 들 수 있습니다.
만성질환의 유병률 증가는 특수 제네릭 시장 수요 증가 요인으로 작용할 것으로 예측됩니다. 만성질환은 대부분 완치는 불가능하지만, 관리와 통제가 가능한 장기적인 병태를 말합니다. 생활습관과 식습관의 변화, 부적절한 체중 관리는 만성질환 증가에 크게 기여하고 있으며, 특정 장기적인 만성 감염은 암 위험을 증가시킬 수 있습니다. 이러한 질환에 대한 노출이 지속적으로 증가함에 따라, 복잡하고 장기적인 질환을 관리하기 위한 전문 제네릭 의약품에 대한 수요가 증가하고 있습니다. 예를 들어, 영국 비영리단체 GOV.UK에 따르면, 2025년 3월 기준 영국 17세 이상 성인의 GP(일반의) 기록상 2형 당뇨병 유병률은 2024년 3월 7.0%로 2023년 3월의 6.8%에서 증가했다고 합니다. 따라서 만성질환의 급증은 특수 제네릭 시장의 성장을 가속하고 있습니다.
전문 제네릭 시장에서 사업을 전개하는 주요 기업들은 효과적인 의약품에 대한 수요 증가에 대응하기 위해 리덱사메페타민 디메실산염과 같은 약품 승인을 획득하고 있습니다. 전문의약품 제네릭 허가란 특허 만료 후 복잡한 질환이나 희귀질환 치료에 사용되는 브랜드 전문의약품과 생물학적 동등성 및 치료적 동등성을 입증한 의약품 제품에 부여되는 규제적 허가를 말합니다. 예를 들어, 2023년 8월 아일랜드에 본사를 둔 전문 제약기업인 말린로드사는 SpecGx LLC 전문 제네릭 부문에서 주의력결핍 및 과잉행동장애(ADHD) 치료제로 리덱사메페타민 디메실레이트 캡슐의 FDA 승인을 획득했습니다. 리덱사메페타민 디메실산염은 ADHD 및 기타 적응증 치료에 사용되는 전문 제네릭 의약품으로, 연방 규제 물질(CII)로 지정되어 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Specialty generics refer to generic versions of complex, high-cost, or high-touch medications that typically require enhanced patient support and specialized handling. These drugs often involve complex formulations, manufacturing processes, or delivery mechanisms and require substantial service participation for effective management. Specialty generics also include biologics and biosimilars, which follow distinct regulatory approval pathways. Most specialty medications are used in the treatment of conditions such as cancer, rheumatoid arthritis, multiple sclerosis, and other chronic or rare diseases.
The main routes of administration for specialty generics include injectables, oral, and other routes. Injectable specialty generics are widely used and can be administered through intravenous, subcutaneous, intradermal, intraperitoneal, intramuscular, and other methods to treat a broad range of medical conditions, from oncology to autoimmune disorders. Drug injections typically involve the use of a hollow hypodermic needle to deliver the medication directly into the bloodstream or targeted tissue. Specialty generics are commonly indicated for oncology, autoimmune diseases, infectious diseases, and other therapeutic areas, and they are distributed through retail pharmacies, specialty pharmacies, and hospital pharmacies.
Tariffs have influenced the specialty generics market by increasing the cost of imported active pharmaceutical ingredients (APIs) and biologics components, thereby impacting production costs. The injectables and oral segments are particularly affected, with North America and Europe facing higher regulatory and cost pressures. While tariffs may raise prices, they also encourage domestic manufacturing investments and local sourcing strategies, fostering innovation and supply chain resilience in the specialty generics sector.
The specialty generics market research report is one of a series of new reports from The Business Research Company that provides specialty generics market statistics, including specialty generics industry global market size, regional shares, competitors with a specialty generics market share, detailed specialty generics market segments, market trends and opportunities, and any further data you may need to thrive in the specialty generics industry. This specialty generics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The specialty generics market size has grown rapidly in recent years. It will grow from $107.14 billion in 2025 to $122.7 billion in 2026 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to rising prevalence of autoimmune diseases, patent expirations of branded specialty drugs, increasing investment in healthcare infrastructure, growth of hospital and retail pharmacy networks, early adoption of biosimilars in key markets.
The specialty generics market size is expected to see rapid growth in the next few years. It will grow to $214.22 billion in 2030 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to expansion of specialty generics portfolio, advancements in biologics manufacturing technology, increasing healthcare expenditure, growing demand for personalized therapies, rising collaborations between pharma companies and CDMOs. Major trends in the forecast period include growth in biologics and biosimilars adoption, expansion of specialty pharmacy services, personalized medicine integration, increasing regulatory compliance complexity, rise in chronic disease treatment demand.
The rising prevalence of chronic diseases is expected to drive demand in the specialty generics market. Chronic diseases are long-term conditions that often cannot be completely cured but can be managed or controlled in many cases. Changes in lifestyle, dietary habits, and poor weight management contribute significantly to the increasing incidence of chronic conditions, while certain long-standing chronic infections can elevate the risk of cancer. As exposure to these diseases continues to grow, the need for specialty generics to manage complex and long-term conditions is increasing. For instance, in March 2025, according to GOV.UK, a UK-based non-profit government organization, GP-recorded type 2 diabetes prevalence among adults aged 17 and over in England reached 7.0% in March 2024, up from 6.8% in March 2023. Therefore, the surge in chronic diseases is fueling the growth of the specialty generics market.
Major companies operating in the specialty generic market are obtaining approvals for drugs such as Lisdexamfetamine Dimesylate to meet the growing need for effective medications. Approval in specialty generics refers to the regulatory authorization granted to pharmaceutical products that demonstrate bioequivalence and therapeutic equivalence to branded specialty drugs, which are typically used to treat complex or rare medical conditions after patent expiration. For instance, in August 2023, Mallinckrodt plc, an Ireland-based specialty pharmaceutical company, received FDA approval for its Lisdexamfetamine Dimesylate Capsules under the SpecGx LLC Specialty Generics segment for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). Lisdexamfetamine dimesylate is a specialty generic and a federally controlled substance (CII) used in the treatment of ADHD and other indications.
In March 2025, Mallinckrodt Pharmaceuticals, an Ireland-based provider of specialty pharmaceuticals, specialty generics, sterile injectables, and active pharmaceutical ingredients (APIs), merged with Endo Inc. for an enterprise value of approximately US$6.7 billion. Through this merger, the companies aim to combine their specialty generics and sterile injectables capabilities, generating operational synergies across manufacturing, regulatory compliance, and research and development. The transaction also includes plans for a future spin-off of the combined generics and sterile injectables business as a standalone entity. This merger highlights the ongoing consolidation within the specialty generics market and reflects a strategic focus on high-barrier, complex generics and sterile injectable products. Endo Inc. is a US-based provider of generics and sterile injectable products.
Major companies operating in the specialty generics market are Teva Pharmaceutical Industries Ltd., Endo International plc, Akorn Operating Company LLC, Mallinckrodt Pharmaceuticals, Dr. Reddy's Laboratories Ltd., Fresenius Kabi Brasil Ltda, STADA Arzneimittel AG, Cipla Limited, Lupin Ltd, Aurobindo Pharma Limited, Aspen Pharmacare Holdings Limited, Pfizer Inc., Accord Healthcare Limited, Amneal Pharmaceuticals Inc., Sandoz International GmbH, Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Impax Laboratories Inc., Par Pharmaceutical Companies Inc., Alvogen, Alkem Laboratories Ltd., Wockhardt Ltd., Strides Pharma Science Limited, Indoco Remedies Ltd., Unichem Laboratories Ltd., Alembic Pharmaceuticals Ltd., Jubilant Life Sciences Ltd.
North America was the largest region in the specialty generics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specialty generics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the specialty generics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The specialty generics market consists of sales of biologics and biosimilars. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Specialty Generics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses specialty generics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for specialty generics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The specialty generics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Route Of Administration: Injectables; Oral; Other Routes Of Administration
2) By Indication: Oncology; Autoimmune Diseases; Infectious Diseases; Other Indications
3) By Distribution Channel: Retail Pharmacies; Specialty Pharmacies; Hospital Pharmacies
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Growth in Biologics and Biosimilars Adoption
4.2.2 Expansion of Specialty Pharmacy Services
4.2.3 Personalized Medicine Integration
4.2.4 Increasing Regulatory Compliance Complexity
4.2.5 Rise in Chronic Disease Treatment Demand
5. Specialty Generics Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Specialty Clinics
5.3 Retail Pharmacies
5.4 Specialty Pharmacies
5.5 Research Institutes
6. Specialty Generics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Specialty Generics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Specialty Generics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Specialty Generics Market Size, Comparisons And Growth Rate Analysis
7.3. Global Specialty Generics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Specialty Generics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Specialty Generics Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Specialty Generics Market Segmentation
9.1. Global Specialty Generics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Injectables, Oral, Other Route Of Administration
9.2. Global Specialty Generics Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oncology, Autoimmune Diseases, Infectious Diseases, Other Indication
9.3. Global Specialty Generics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.5. Global Specialty Generics Market, Sub-Segmentation Of Oral, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Tablets, Capsules, Liquid Formulations
9.6. Global Specialty Generics Market, Sub-Segmentation Of Other Route Of Administration, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Topical, Transdermal, Inhalation
10. Specialty Generics Market Regional And Country Analysis
10.1. Global Specialty Generics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Specialty Generics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Specialty Generics Market
12.1. China Specialty Generics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Specialty Generics Market
13.1. India Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Specialty Generics Market
14.1. Japan Specialty Generics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Specialty Generics Market
15.1. Australia Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Specialty Generics Market
16.1. Indonesia Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Specialty Generics Market
17.1. South Korea Specialty Generics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Specialty Generics Market
18.1. Taiwan Specialty Generics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Specialty Generics Market
19.1. South East Asia Specialty Generics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Specialty Generics Market
20.1. Western Europe Specialty Generics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Specialty Generics Market
21.1. UK Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Specialty Generics Market
22.1. Germany Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Specialty Generics Market
23.1. France Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Specialty Generics Market
24.1. Italy Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Specialty Generics Market
25.1. Spain Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Specialty Generics Market
26.1. Eastern Europe Specialty Generics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Specialty Generics Market
27.1. Russia Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Specialty Generics Market
28.1. North America Specialty Generics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Specialty Generics Market
29.1. USA Specialty Generics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Specialty Generics Market
30.1. Canada Specialty Generics Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Specialty Generics Market
31.1. South America Specialty Generics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Specialty Generics Market
32.1. Brazil Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Specialty Generics Market
33.1. Middle East Specialty Generics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Specialty Generics Market
34.1. Africa Specialty Generics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Specialty Generics Market, Segmentation By Route Of Administration, Segmentation By Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Specialty Generics Market Regulatory and Investment Landscape
36. Specialty Generics Market Competitive Landscape And Company Profiles
36.1. Specialty Generics Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Specialty Generics Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Specialty Generics Market Company Profiles
36.3.1. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Endo International plc Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Akorn Operating Company LLC Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Mallinckrodt Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Dr. Reddy's Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
37. Specialty Generics Market Other Major And Innovative Companies
Fresenius Kabi Brasil Ltda, STADA Arzneimittel AG, Cipla Limited, Lupin Ltd, Aurobindo Pharma Limited, Aspen Pharmacare Holdings Limited, Pfizer Inc., Accord Healthcare Limited, Amneal Pharmaceuticals Inc., Sandoz International GmbH, Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Impax Laboratories Inc., Par Pharmaceutical Companies Inc.
38. Global Specialty Generics Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Specialty Generics Market
40. Specialty Generics Market High Potential Countries, Segments and Strategies
40.1 Specialty Generics Market In 2030 - Countries Offering Most New Opportunities
40.2 Specialty Generics Market In 2030 - Segments Offering Most New Opportunities
40.3 Specialty Generics Market In 2030 - Growth Strategies
